- Home
- Publications
- Publication Search
- Publication Details
Title
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-17
DOI
10.3389/fimmu.2021.672356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Targeting a neoantigen derived from a common TP53 mutation
- (2021) Emily Han-Chung Hsiue et al. SCIENCE
- Bispecific antibodies targeting mutant RAS neoantigens
- (2021) Jacqueline Douglass et al. Science Immunology
- Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
- (2020) Shaherin Basith et al. MEDICINAL RESEARCH REVIEWS
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
- (2020) Monica S. Thakar et al. Frontiers in Oncology
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
- (2020) Chongxian Pan et al. Journal of Hematology & Oncology
- Editorial: Harnessing the power of the immune system in cancer immunotherapy and cancer prevention
- (2020) Yong‐Chen Lu et al. MOLECULAR CARCINOGENESIS
- Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy
- (2020) Wenyi Zhao et al. PHARMACOGENOMICS
- An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
- (2020) Guan Wang et al. Nature Communications
- Immunotherapies and Combination Strategies for Immuno-Oncology
- (2020) Cody Barbari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
- (2020) Colby S. Shemesh et al. MOLECULAR THERAPY
- The Oncolytic Virus in Cancer Diagnosis and Treatment
- (2020) Guo-dong Cao et al. Frontiers in Oncology
- The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma
- (2020) Joji Nagasaki et al. Blood Advances
- Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas
- (2019) Susan K. Rathe et al. Scientific Reports
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
- (2019) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- In Situ Nanoadjuvant-Assembled Tumor Vaccine for Preventing Long-Term Recurrence
- (2019) Quoc-Viet Le et al. ACS Nano
- Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
- (2019) Felix L. Fennemann et al. Frontiers in Immunology
- On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment
- (2019) Grazia R. Tundo et al. CHEMOTHERAPY
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Toward in silico Identification of Tumor Neoantigens in Immunotherapy
- (2019) Chi Zhou et al. TRENDS IN MOLECULAR MEDICINE
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
- (2019) Xi Li et al. Frontiers in Oncology
- Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
- (2019) Abdolreza Esmaeilzadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information
- (2018) S Kim et al. ANNALS OF ONCOLOGY
- Whole genome sequencing analysis for cancer genomics and precision medicine
- (2018) Hidewaki Nakagawa et al. CANCER SCIENCE
- Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
- (2018) Mengjia Song et al. Chinese Journal of Cancer Research
- Cancer immunotherapy beyond immune checkpoint inhibitors
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
- (2018) Xiaolei Li et al. Journal of Hematology & Oncology
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
- (2018) Janos L. Tanyi et al. Science Translational Medicine
- Challenges towards the realization of individualized cancer vaccines
- (2018) Özlem Türeci et al. Nature Biomedical Engineering
- Predicting T cell recognition of MHC class I restricted neoepitopes
- (2018) Zeynep Koşaloğlu-Yalçın et al. OncoImmunology
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
- (2018) Sandra Wagner et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
- (2018) Ren-You Pan et al. Journal of Immunology Research
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Shared cancer neoantigens: Making private matters public
- (2017) Christopher A. Klebanoff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New development in CAR-T cell therapy
- (2017) Zhenguang Wang et al. Journal of Hematology & Oncology
- Advances in Immunotherapy for Melanoma: A Comprehensive Review
- (2017) Carmen Rodríguez-Cerdeira et al. MEDIATORS OF INFLAMMATION
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- The Future of Immunotherapy: A 20-Year Perspective
- (2017) David C. Wraith Frontiers in Immunology
- The immune system in cancer metastasis: friend or foe?
- (2017) Louise M.E. Janssen et al. Journal for ImmunoTherapy of Cancer
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Emerging Opportunities and Challenges in Cancer Immunotherapy
- (2016) T. L. Whiteside et al. CLINICAL CANCER RESEARCH
- Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
- (2016) Shengmeng Di et al. Science China-Life Sciences
- The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
- (2016) Pankita H. Pandya et al. Journal of Immunology Research
- Immune monitoring technology primer: whole exome sequencing for neoantigen discovery and precision oncology
- (2016) Pia Kvistborg et al. Journal for ImmunoTherapy of Cancer
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- Active Immunotherapy of Cancer
- (2015) Thinle Chodon et al. IMMUNOLOGICAL INVESTIGATIONS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Active and passive immunization for cancer
- (2014) David Baxter Human Vaccines & Immunotherapeutics
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started